77 related articles for article (PubMed ID: 2131037)
1. Cisplatin-induced anemia: a potential interference with iron metabolism at erythroid progenitors level.
Dufour P; Bergerat JP; Eber M; Renaud P; Karcher V; Giron C; Leroy MJ; Oberling F
Anticancer Drugs; 1990 Oct; 1(1):49-54. PubMed ID: 2131037
[TBL] [Abstract][Full Text] [Related]
2. Platin salts-induced hemolytic anemia: cisplatin- and the first case of carboplatin-induced hemolysis.
Maloisel F; Kurtz JE; Andres E; Gorodetsky C; Dufour P; Oberling F
Anticancer Drugs; 1995 Apr; 6(2):324-6. PubMed ID: 7795280
[TBL] [Abstract][Full Text] [Related]
3. [Effects of massive administration of cepharanthin on chemotherapy-induced leukopenia].
Asukai K; Kimura A; Gorai I; Uemura T; Minaguchi H
Gan To Kagaku Ryoho; 1989 Aug; 16(8 Pt 1):2583-7. PubMed ID: 2774588
[TBL] [Abstract][Full Text] [Related]
4. Long-term survival in advanced ovarian cancer after cytoreduction and chemotherapy treatment.
Del Campo JM; Felip E; Rubio D; Vidal R; Bermejo B; Colomer R; Zanon V
Gynecol Oncol; 1994 Apr; 53(1):27-32. PubMed ID: 8175018
[TBL] [Abstract][Full Text] [Related]
5. [In vitro and in vivo studies of murine erythropoietic recovery after treatment with cyclophosphamide].
Aguirre MV; Juaristi JA; Alba Alvarez M; Carmuega RJ; Brandan NC
Sangre (Barc); 1999 Jun; 44(3):182-7. PubMed ID: 10481578
[TBL] [Abstract][Full Text] [Related]
6. Non-protein bound iron release during chemotherapy in cancer patients.
Weijl NI; Elsendoorn TJ; Moison RM; Lentjes EG; Brand R; Berger HM; Osanto S
Clin Sci (Lond); 2004 May; 106(5):475-84. PubMed ID: 14670072
[TBL] [Abstract][Full Text] [Related]
7. Long-term survival of patients with advanced ovarian carcinoma treated with cisplatin-based chemotherapy regimens.
De Pree N; Wils J
Anticancer Res; 1989; 9(6):1869-71. PubMed ID: 2697190
[TBL] [Abstract][Full Text] [Related]
8. Phase III trial of doxorubicin with or without cisplatin in advanced endometrial carcinoma: a gynecologic oncology group study.
Thigpen JT; Brady MF; Homesley HD; Malfetano J; DuBeshter B; Burger RA; Liao S
J Clin Oncol; 2004 Oct; 22(19):3902-8. PubMed ID: 15459211
[TBL] [Abstract][Full Text] [Related]
9. [A case of recurrent endometrial cancer (clear cell adenocarcinoma) remarkably responsive to combination chemotherapy containing cisplatin].
Kitayama S; Iwahashi M; Iwahashi M; Yamoto M; Nakano R
Gan To Kagaku Ryoho; 1989 May; 16(5):2099-101. PubMed ID: 2730095
[TBL] [Abstract][Full Text] [Related]
10. [Chemotherapy of disseminated forms of breast cancer using platinum derivatives].
Gorbunova VA; Trofimova NB; Manziuk LV
Vopr Onkol; 1990; 36(4):455-7. PubMed ID: 2345995
[TBL] [Abstract][Full Text] [Related]
11. Hydration regimen and hematological toxicity of a cisplatin-based chemotherapy regimen. Clinical observations and pharmacokinetic analysis.
Numico G; Benasso M; Vannozzi MO; Merlano M; Rosso R; Viale M; Esposito M
Anticancer Res; 1998; 18(2B):1313-8. PubMed ID: 9615808
[TBL] [Abstract][Full Text] [Related]
12. [Peripheral neuropathy caused by cisplatin in patients with lung cancer].
Murata M; Yamaji Y; Futami H; Shimada Y; Fujita J; Hashimoto Y; Shiotani T; Irino S
Gan To Kagaku Ryoho; 1989 Jun; 16(6):2283-8. PubMed ID: 2544151
[TBL] [Abstract][Full Text] [Related]
13. Combination chemotherapy with cisplatin and/or doxorubicin in malignant mesothelioma. A retrospective study [corrected from prospective].
Tsavaris N; Primikirios N; Mylonakis N; Varouchakis G; Dosios T; Pavlidis N; Skarlos D; Tasopoulos T; Dritsas J; Kosmidis P
Anticancer Res; 1997; 17(5B):3799-802. PubMed ID: 9427783
[TBL] [Abstract][Full Text] [Related]
14. [Combination chemotherapy with cis-diamminedichloroplatinum (CDDP) and other anticancer agents for patients with advanced esophageal cancer].
Yoshihara T; Niimoto M; Hirai T; Miyoshi Y; Ohtagaki S; Hattori T
Gan To Kagaku Ryoho; 1985 Jun; 12(6):1286-93. PubMed ID: 2408579
[TBL] [Abstract][Full Text] [Related]
15. [Chemotherapy of advanced genitourinary carcinoma with cis-diamminedichloroplatinum].
Uchida T; Kobayashi K; Arakawa T; Omata T; Li K; Ikeda S; Endo T; Ishibashi A; Koshiba K
Hinyokika Kiyo; 1984 Sep; 30(9):1173-83. PubMed ID: 6084421
[TBL] [Abstract][Full Text] [Related]
16. [Beneficial effect of cisplatin based combination chemotherapy on adenocarcinoma of the lung].
Ueoka H; Ohnoshi T; Numata T; Kawahara S; Nishii K; Yonei T; Yamashita H; Ishii J; Moritaka T; Kiura K
Gan To Kagaku Ryoho; 1989 Nov; 16(11):3559-65. PubMed ID: 2479339
[TBL] [Abstract][Full Text] [Related]
17. [TS-1/CDDP therapy for advanced gastric cancer as neoadjuvant chemotherapy].
Nakamura M; Maruyama K; Furukawa J; Maruyama N; Tanaka J; Katsumoto Y; Yokouchi H; Nakaguchi K; Sue F; Yoshihara W
Gan To Kagaku Ryoho; 2002 Oct; 29(10):1823-8. PubMed ID: 12402437
[TBL] [Abstract][Full Text] [Related]
18. [Chemotherapy of metastatic urothelial carcinoma. cis-Diamminedichloroplatinum combination chemotherapy for patients with decreased renal function].
Kihara K; Kusuyama H; Washizuka M; Kawai T
Hinyokika Kiyo; 1984 Jan; 30(1):21-8. PubMed ID: 6539559
[TBL] [Abstract][Full Text] [Related]
19. Chemotherapy consisting of cisplatin, doxorubicin and cyclophosphamide as an adjunct to surgery in stage Ic-II epithelial ovarian carcinoma. Gynecologic Oncology Group of the Comprehensive Cancer Center Limburg.
De Pree N; Wils J
Anticancer Res; 1989; 9(6):1873-5. PubMed ID: 2697191
[TBL] [Abstract][Full Text] [Related]
20. [Intraperitoneal (Ip) administration of cisplatin in combination with systemic chemotherapy in patients with malignant ascites of gastrointestinal cancer: clinical evaluation and pharmacokinetics].
Koda K; Nakazawa O; Terada S; Kure T; Morita K; Hirayama M; Fukushi A; Terui T; Yoshizaki N; Takahashi H
Gan No Rinsho; 1988 Feb; 34(2):191-5. PubMed ID: 3126333
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
